Robert Friesen
Chief Tech/Sci/R&D Officer en PHARMING GROUP N.V. .
Perfil
Presently, Robert Friesen occupies the position of Chief Scientific Officer at Pharming Group NV.
In the past he occupied the position of Head-Preclinical & Early Clinical Development at MorphoSys AG, Senior Vice President of ProQR Therapeutics NV, Global Head-Biologics Research at Janssen Biotherapeutics, Chief Scientific Officer for Ablynx NV, Chief Scientific Officer for Kiadis Pharma NV and Vice President-Biologics Research at Janssen Research & Development LLC.
He received a doctorate from The University of Texas at Austin and a graduate degree from the University of Utrecht.
Cargos activos de Robert Friesen
Empresas | Cargo | Inicio |
---|---|---|
PHARMING GROUP N.V. | Chief Tech/Sci/R&D Officer | 01/08/2021 |
Antiguos cargos conocidos de Robert Friesen.
Empresas | Cargo | Fin |
---|---|---|
KIADIS PHARMA N.V. | Chief Tech/Sci/R&D Officer | 01/08/2021 |
ABLYNX | Chief Tech/Sci/R&D Officer | 01/01/2019 |
PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/02/2018 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01/06/2016 |
MORPHOSYS AG | Corporate Officer/Principal | 01/07/2008 |
Formación de Robert Friesen.
The University of Texas at Austin | Doctorate Degree |
University of Utrecht | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
MORPHOSYS AG | Health Technology |
PHARMING GROUP N.V. | Health Technology |
PROQR THERAPEUTICS N.V. | Health Technology |
Empresas privadas | 4 |
---|---|
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Janssen Biotherapeutics |